AstraZeneca Net Worth 2006-2018 | AZN

Interactive chart of historical net worth (market cap) for AstraZeneca (AZN) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. AstraZeneca net worth as of February 19, 2019 is $103.65B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $103.646B $22.090B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $365.894B 16.67
Pfizer (PFE) United States $252.401B 14.13
Merck (MRK) United States $215.183B 18.39
Novartis AG (NVS) Switzerland $207.623B 17.66
Eli Lilly (LLY) United States $129.746B 22.03
Novo Nordisk (NVO) Denmark $123.032B 19.90
AbbVie (ABBV) United States $121.616B 10.22
Sanofi (SNY) France $106.719B 13.17
GlaxoSmithKline (GSK) United Kingdom $102.300B 13.43
Bristol-Myers Squibb (BMY) United States $84.336B 12.98